definiens: means, Vvith respect to the Foundation 5214 Patent Rights, the use of a Licensed Product, which is a singlc pharmaceutical composition that contains within such pharmaceutical composition ( a ) a therapeutic or prophylactic agent and ( b ) one or more nano - scale or micro - scale compartments containing either ( i ) a different therapeutic and/or prophylactic agent or ( ii ) a different formulation orthe agent described in ( a ), for the treatment andlor prevention of disease in humans . For the avoidance of doubt, the Field, with respect to the Foundation 5214 Patent Rights, does not include the use of a Licensed Product which is a physical mixture or t'>',,'O separate phannaceutical compositions, each containing a single therapeutic or prophylactic agent . Field " means, with rcspect to the Foundation 5431 Patent Rights, the usc of a Licensed Product, which is a single nanoparticle composition that contains within sllch nanoparticlc composition ( a ) onc or more therapcutic or prophylactic agents or one or more different formulations or release protiles of the same agent and ( b ) either ( i ) a polyeltbylcne glycol moiety \\"hich is associated \\ith a lipid, surfactant, polymer, dlUg, prodrug or other material included in the nanopartic1e composition or ( ii ) a molecule . as described in the Foundation 5431 Patent Rights . \vhich improves the physical stability of a taxane in the nanoparticlc composition, for the treatment and/or prevention of disease in humans